Literature DB >> 20051132

A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.

Peter Calabrese1, Darryl Shibata.   

Abstract

BACKGROUND: The purpose of this article is to present a relatively easy to understand cancer model where transformation occurs when the first cell, among many at risk within a colon, accumulates a set of driver mutations. The analysis of this model yields a simple algebraic equation, which takes as inputs the number of stem cells, mutation and division rates, and the number of driver mutations, and makes predictions about cancer epidemiology.
METHODS: The equation [p = 1 - (1 - (1 - (1 - u)d)k)Nm ] calculates the probability of cancer (p) and contains five parameters: the number of divisions (d), the number of stem cells (N x m), the number of critical rate-limiting pathway driver mutations (k), and the mutation rate (u). In this model progression to cancer "starts" at conception and mutations accumulate with cell division. Transformation occurs when a critical number of rate-limiting pathway mutations first accumulates within a single stem cell.
RESULTS: When applied to several colorectal cancer data sets, parameter values consistent with crypt stem cell biology and normal mutation rates were able to match the increase in cancer with aging, and the mutation frequencies found in cancer genomes. The equation can help explain how cancer risks may vary with age, height, germline mutations, and aspirin use. APC mutations may shorten pathways to cancer by effectively increasing the numbers of stem cells at risk.
CONCLUSIONS: The equation illustrates that age-related increases in cancer frequencies may result from relatively normal division and mutation rates. Although this equation does not encompass all of the known complexity of cancer, it may be useful, especially in a teaching setting, to help illustrate relationships between small and large cancer features.

Entities:  

Mesh:

Year:  2010        PMID: 20051132      PMCID: PMC2829925          DOI: 10.1186/1471-2407-10-3

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  42 in total

1.  Investigating stem cells in human colon by using methylation patterns.

Authors:  Y Yatabe; S Tavaré; D Shibata
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Mutation selection and the natural history of cancer.

Authors:  J Cairns
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

3.  Intestinal length in man.

Authors:  B M UNDERHILL
Journal:  Br Med J       Date:  1955-11-19

Review 4.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

5.  The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.

Authors:  S Dihlmann; A Siermann; M von Knebel Doeberitz
Journal:  Oncogene       Date:  2001-02-01       Impact factor: 9.867

6.  Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States.

Authors:  P Herrero-Jimenez; A Tomita-Mitchell; E E Furth; S Morgenthaler; W G Thilly
Journal:  Mutat Res       Date:  2000-01-17       Impact factor: 2.433

7.  Increased cell division as a cause of human cancer.

Authors:  S Preston-Martin; M C Pike; R K Ross; P A Jones; B E Henderson
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

Review 10.  Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt.

Authors:  C S Potten; M Loeffler
Journal:  Development       Date:  1990-12       Impact factor: 6.868

View more
  27 in total

Review 1.  Mutation and epigenetic molecular clocks in cancer.

Authors:  Darryl Shibata
Journal:  Carcinogenesis       Date:  2010-11-12       Impact factor: 4.944

2.  Spatial structure increases the waiting time for cancer.

Authors:  Erik A Martens; Rumen Kostadinov; Carlo C Maley; Oskar Hallatschek
Journal:  New J Phys       Date:  2011-11-28       Impact factor: 3.729

3.  Sporadic colorectal cancer: Studying ways to an end.

Authors:  Isadora Rosa; Paulo Fidalgo; Bruno Filipe; Cristina Albuquerque; Ricardo Fonseca; Paula Chaves; António D Pereira
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

Review 4.  Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?

Authors:  Jeff M P Holly; Li Zeng; Claire M Perks
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 5.  Peto's Paradox: evolution's prescription for cancer prevention.

Authors:  Aleah F Caulin; Carlo C Maley
Journal:  Trends Ecol Evol       Date:  2011-04       Impact factor: 17.712

6.  Peto's paradox and the promise of comparative oncology.

Authors:  Leonard Nunney; Carlo C Maley; Matthew Breen; Michael E Hochberg; Joshua D Schiffman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

7.  Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL).

Authors:  Natalia L Komarova; Jan A Burger; Dominik Wodarz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

8.  Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.

Authors:  Lisa M Abegglen; Aleah F Caulin; Ashley Chan; Kristy Lee; Rosann Robinson; Michael S Campbell; Wendy K Kiso; Dennis L Schmitt; Peter J Waddell; Srividya Bhaskara; Shane T Jensen; Carlo C Maley; Joshua D Schiffman
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

9.  Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells.

Authors:  Euan S Polson; John L Lewis; Hamza Celik; Vincent M Mann; Michael J Stower; Matthew S Simms; Greta Rodrigues; Anne T Collins; Norman J Maitland
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  The real war on cancer: the evolutionary dynamics of cancer suppression.

Authors:  Leonard Nunney
Journal:  Evol Appl       Date:  2012-10-10       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.